New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
MediPharm Labs Corp.
LABS.TO
Shape
US Flag

TSX

Unprofitable

EPS improving

Unprofitable

EPS improving

31M

Drug Manufacturers - Specialty & Generic

Next Earning date - 14 Nov 2024

31M

Drug Manufacturers - Specialty & Generic

Next Earning date - 14 Nov 2024

0.07CAD
Shape-0.01 ( -6.25%)
Market Open
favorite-chart

Relative Strenght

favorite-chart

Volume Buzz

54%
favorite-chart

Earning Acce

No
favorite-chart

Dist 52w H.

25%

Quote Panel

Shape
Updated October 22, 2024
1W 0.00 % 1M 7.14 % 3M 7.14 % 1Y 7.14 %

Key Metrics

Shape
  • Market Cap

    30.83M


  • Shares Outstanding

    411.05M


  • Share in Float

    388.51M


  • Dividende

    0


  • Earning Date

    14 Nov 2024


  • Price Target

    0.075


  • Average Volume

    172088


  • Beta

    0.88


  • Range

    0.06-0.1


  • Industry

    Drug Manufacturers - Specialty & Generic


  • Website

    https://www.medipharmlabs.com


  • Sector

    Healthcare


Fundamentals

Shape

N/A

P/E Ratio

0.87x

P/S Ratio

0.68x

P/B Ratio

0.1

Debt/Equity

-35.7%

Net Margin

$-0.0

EPS

How LABS.TO compares to sector?

P/E Ratio

Relative Strength

Shape

LABS.TO

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$55M

Shape431%

2025-Revenue

$0.01

Shape22%

2025-EPS

$38M

Shape-2191%

2025-EBITDA

Analyst rating

No Data Available

Last analyst upgrade/downgrade

No Data Available

Earnings GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

N/A

-0.03
vs -0.03

Q4.22

arrow
arrow

N/A

-0.02
vs -0.08

Q1.23

arrow
arrow

N/A

-0.01
vs -0.03

Q2.23

arrow
arrow

N/A

-0.01
vs -0.03

Q3.23

arrow
arrow

N/A

-0.01
vs -0.03

Q4.23

arrow
arrow

N/A

-0.01
vs -0.02

Q1.24

arrow
arrow

N/A

-0.01
vs -0.01

Q2.24

arrow
arrow

N/A

-0.01
vs -0.01

Q3.24

arrow
arrow

N/A

-0.00
vs -0.01

Q4.24

arrow
arrow

N/A

-0.00
vs -0.01

Sales GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

+34%

7.3M  vs 5.4M

Q4.22

arrow
arrow

-2%

5.6M  vs 5.7M

Q1.23

arrow
arrow

+20%

5.8M  vs 4.9M

Q2.23

arrow
arrow

+120%

9.6M  vs 4.4M

Q3.23

arrow
arrow

+17%

8.5M  vs 7.3M

Q4.23

arrow
arrow

+63%

9.1M  vs 5.6M

Q1.24

arrow
arrow

+67%

9.8M  vs 5.8M

Q2.24

arrow
arrow

+8%

10.3M  vs 9.6M

Q3.24

arrow
arrow

+44%

12.2M  vs 8.5M

Q4.24

arrow
arrow

+46%

13.3M  vs 9.1M

Return on EquityShape

status-upQoQ

Q3.22

arrow
arrow

-13%

-0.13
vs -0.13

Q4.22

arrow
arrow

-10%

-0.10
vs -0.13

Q1.23

arrow
arrow

-6%

-0.06
vs -0.10

Q2.23

arrow
arrow

-5%

-0.05
vs -0.06

Q3.23

arrow
arrow

-8%

-0.08
vs -0.05

Q4.23

arrow
arrow

-6%

-0.06
vs -0.08

Q1.24

arrow
arrow

-7%

-0.07
vs -0.06

Q2.24

arrow
arrow

-5%

-0.05
vs -0.07

Institutionnal OwnershipShape

status-up

Earnings Growth

Latest News